Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L15 pseudogene 14 (RPL15P14) is a processed pseudogene in the human genome, related by sequence to the functional ribosomal protein L15 gene (RPL15)[6]. Pseudogenes like RPL15P14 are genomic DNA sequences similar to normal genes but nonfunctional; they do not encode active protein products and do not have known biological activity or direct involvement in disease, drug interaction, or serve as therapeutic targets[6][2]. RPL15P14 is a sequence-inactive pseudogene, related to the gene encoding ribosomal protein L15 but not producing a protein or participating in known biological pathways. It is not considered a valid target in the context of therapeutic research, and listing or analyzing it as a receptor, enzyme, or other drug-interaction site would be inaccurate[6][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 14 (RPL15P14).